with delivering ended CRA in XXXX the company's results everyone. continued year entire performance full the morning, good fiscal and Chad, best across strong Thanks, our portfolio, history.
impressive utilization end the more XX% XX% the which to double-digit What the of in growth our our over the from of year-over-year we of XXX, our rate This since growth period. investment portfolio increase delivering that reflects services, is demand ninth profit XX% same fiscal even consulting period. is quarter of broad-based quarter. XXXX, across fourth the headcount, grown fiscal consecutive with over During revenue has growth for to an combined continued of XXXX experienced by
than XX% example, and Building net while grew For and income respectively. non-GAAP net performance, increased EBITDA non-GAAP XX% XX%, fiscal and while income XX% by XXXX XXXX, year-over-year, strong this XX% fiscal with XXXX grew fiscal on compared more by EBITDA by and non-GAAP XX%, respectively. revenue increased
closely practice. Services, revenue our fourth and more in Looking at quarter, our was with performance from by the practices solid Sciences Finance, Energy, &Competition driven contributions Economics Forensic Life Antitrust double-digit our growth
& American X% regulatory, also European We and experienced North continuing across practice engagements. Within enjoyed to another quarter, operations strong legal with the geographies Competition Antitrust and operations growing ongoing XX% Economics year-over-year. strength growing merger-related support while
Court Burrows case example, and were states. cases. case. valuation the practice of ultimately provide plan horizontal vertical merger Insurance on the The divestiture on and company. issues in in CVS CRA of President, economic to number consultant, consultants Mark senior concerns subject drug issues testimony the testimony issues pipeline Stillwater Seabron CRA's merger continue Chancery CRA's for expert Columbia addressed Vice both competitive another the raise one prescription on practice DOJ of that provided CRA and Justice trials, of concluded and The Mining Industry departments in expert that prepared or Aetna's Part of addressed Columbia competitive Stillwater advise the D U.S. did not extensive Medicare the U.S. valuation by any Adamson Department two For concerns Jim Aetna. individuals. business other group Finance Vice Zmijewski a for in Delaware Appraisal by in raised analysis for Chairman, to
of seek allegations of noncompliance. to strong across fraud, and a experienced independent industries assistance, growth variety misconduct practice responding as Services when clients Forensic Our
on solutions provide to retained specialized was e-discovery multinational inventory of hit behalf by For was example, company the ransomware. practice incident a cyber that services and response
into to of In to our engaged consultants areas hospice help and Energy provider investigations government and transactional consultants quarter, centered shareholder oil to ongoing energy litigation consulting our support. renewable Energy respond management Statute. arbitration grow were in practice international the industry multistate violations worked continued CRA support, the refining. its false In consulting, in Anti-Kickback strategy fourth and an alleged of a in the Within litigation addition, claims dissenting the around supported matter act
TransCanada and Energy In addition, gas practice a between -- collaboration assisted litigation. in pipeline across cross Finance our practices,
as and supporting the Life performance continued made by the resource District clients Finally, and the benefited over of utilities alternatives. clearly with past assisting such two Empire analysis practice work of years. XXXX from Energy talent regulate Power commercial its planning acquisition Gulf investments NextEra its Sciences
commercial came resulting non-GAAP groups. helping develop of is development guidance CRA currency million, pharmaceutical basis, company ensure our of reported to XXXX For AD basis X.X% revenue a The $XX late-stage to of fiscal million global fiscal $XXX million million client $XXX.X large introduction tailwinds. involved million governments product constant-currency tailwinds, on for efforts $XXX X.X%. consisting blueprints To $X.X country at helping $XX.X of the margin $X.X million, positioning. a targeting margin results optimal closely results strategic patient on in and the in is sclerosis. consisting example, develop strategy a working markets were helped a to the XXXX adjustment opportunity CRA country range in understand for EBITDA their the with and team pharmaceutical companies to currency reported educate and go-to-market These end basis. of XX relative EBITDA non-GAAP non-GAAP a million Full and options is on blockbuster and of Alzheimer cross-functional non-GAAP revenue for our year a crucial of a for upper Recapping non-GAAP drug. also global summarize, and effectively EBITDA consultants the support teams blueprints define engagement to constant-currency constant-currency in a multiple leading asset and to XXXX, basis exceeded of the a constant-currency guidance on we a of adjustment X.X% million $XXX
our demonstrate success in continued performance XXXX fiscal the marketplace. Our
new and project opportunities look of over trend calendar our significantly year. improved and fiscal XXXX broad-based on XXXX. throughout the growth profitable to business grew build We New in originations
XXXX, EBITDA to a of year For relative fiscal revenue to constant-currency fiscal basis, the $XXX range in the XXXX, XX.X%. million on full the non-GAAP $XXX to of of we range million expect and in X.X% margin
And we additional Chad? While comments. remain performance call arising that and a from we around short-term are over conditions business. in to I'll with turn political few global CRA's XXXX, pleased the our uncertainties for mindful can now, Chad affect challenges economic strong